Great Valley Advisor Group’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$76K Buy
+16,198
New +$84K ﹤0.01% 1067

Other funds holding UNCY

Great Valley Advisor Group's UNCY Position: Q3 2026 in Review

Great Valley Advisor Group opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 16,198 shares worth $76K. The stake represents ﹤0.01% of the portfolio and ranks #1067 among its holdings.

93 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • Great Valley Advisor Group held 16,198 shares of Unicycive Therapeutics worth $76K as of Q3 2026.
  • Unicycive Therapeutics was a new Great Valley Advisor Group position in Q3 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Great Valley Advisor Group's portfolio in Q3 2026, its #1067 holding.
  • 93 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on Great Valley Advisor Group's 13F filing for Q3 2026, filed 9 Nov 2026.